What is the current valuation of the Gastroenterology Ambulatory Surgery Center Market?

The market valuation reached 36.89 USD Billion in 2024. Read More

What is the projected market size for the Gastroenterology Ambulatory Surgery Center Market by 2035?

The market is expected to grow to 119.93 USD Billion by 2035. Read More

Which segments are leading in the Gastroenterology Ambulatory Surgery Center Market?

The leading segments include Gastrointestinal Endoscopy, with a valuation range of 8.0 to 25.0 USD Billion. Read More

How does the market perform in terms of patient population segments?

The adult patient population segment is valued between 24.0 and 80.0 USD Billion. Read More

What are the key players in the Gastroenterology Ambulatory Surgery Center Market?

Key players include United Surgical Partners International, Surgical Care Affiliates, and HCA Healthcare. Read More

What is the valuation range for Upper Endoscopy in the market?

Upper Endoscopy is valued between 8.0 and 25.0 USD Billion. Read More

What is the expected performance of imaging modalities in the market?

Computed Tomography (CT) is projected to have a valuation range of 16.89 to 56.93 USD Billion. Read More

What is the market outlook for same-day surgery procedures?

Same-Day Surgery is expected to be valued between 12.0 and 38.0 USD Billion. Read More

How does the market segment for endoscopy types perform?

The Lower Endoscopy segment is projected to range from 10.0 to 35.0 USD Billion. Read More

Gastroenterology Ambulatory Surgery Center Market

Q: What is the expected CAGR for the Gastroenterology Ambulatory Surgery Center Market during the forecast period?

The market is projected to experience a CAGR of 11.31% from 2025 to 2035. Read More

ID: MRFR/HC/27618-HCR

128 Pages

Rahul Gotadki

Last Updated: May 14, 2026

Gastroenterology Ambulatory Surgery Center Market Research Report By Procedure Type (Gastrointestinal Endoscopy, Colon and Rectal Surgery, Upper Gastrointestinal Surgery, Laparoscopic Surgery, Endoscopic Retrograde Cholangiopancreatography (ERCP), Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement, Esophageal Dilatation, Endoscopic Mucosal Resection (EMR), Endoscopic Submucosal Dissection (ESD)), By Endoscopy Type (Upper Endoscopy, Lower Endoscopy, Capsule Endoscopy, Wireless Capsule Endoscopy, Double-Balloon Endoscopy), By Imaging Modality (Fluoroscopy, Ultrasound, Magnetic Resonance Imaging (MRI), Computed Tomography (CT)), By Patient Population (Adults, Children, Geriatric Patients), By Level of Care (Same-Day Surgery, Observation, Inpatient) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

Gastroenterology Ambulatory Surgery Center Market Infographic

Summary Table of Contents Segmentation Download PDF

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Procedure Type (USD Billion)
  1. 4.1.1 Gastrointestinal Endoscopy
  2. 4.1.2 Colon and Rectal Surgery
  3. 4.1.3 Upper Gastrointestinal Surgery
  4. 4.1.4 Laparoscopic Surgery
  5. 4.1.5 Endoscopic Retrograde Cholangiopancreatography (ERCP)
  6. 4.1.6 Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement
  7. 4.1.7 Esophageal Dilatation
  8. 4.1.8 Endoscopic Mucosal Resection (EMR)
  9. 4.1.9 Endoscopic Submucosal Dissection (ESD)
2. 4.2 Healthcare, BY Endoscopy Type (USD Billion)
  1. 4.2.1 Upper Endoscopy
  2. 4.2.2 Lower Endoscopy
  3. 4.2.3 Capsule Endoscopy
  4. 4.2.4 Wireless Capsule Endoscopy
  5. 4.2.5 Double-Balloon Endoscopy
3. 4.3 Healthcare, BY Imaging Modality (USD Billion)
  1. 4.3.1 Fluoroscopy
  2. 4.3.2 Ultrasound
  3. 4.3.3 Magnetic Resonance Imaging (MRI)
  4. 4.3.4 Computed Tomography (CT)
4. 4.4 Healthcare, BY Patient Population (USD Billion)
  1. 4.4.1 Adults
  2. 4.4.2 Children
  3. 4.4.3 Geriatric Patients
5. 4.5 Healthcare, BY Level of Care (USD Billion)
  1. 4.5.1 Same-Day Surgery
  2. 4.5.2 Observation
  3. 4.5.3 Inpatient
6. 4.6 Healthcare, BY Region (USD Billion)
  1. 4.6.1 North America
    1. 4.6.1.1 US
    2. 4.6.1.2 Canada
  2. 4.6.2 Europe
    1. 4.6.2.1 Germany
    2. 4.6.2.2 UK
    3. 4.6.2.3 France
    4. 4.6.2.4 Russia
    5. 4.6.2.5 Italy
    6. 4.6.2.6 Spain
    7. 4.6.2.7 Rest of Europe
  3. 4.6.3 APAC
    1. 4.6.3.1 China
    2. 4.6.3.2 India
    3. 4.6.3.3 Japan
    4. 4.6.3.4 South Korea
    5. 4.6.3.5 Malaysia
    6. 4.6.3.6 Thailand
    7. 4.6.3.7 Indonesia
    8. 4.6.3.8 Rest of APAC
  4. 4.6.4 South America
    1. 4.6.4.1 Brazil
    2. 4.6.4.2 Mexico
    3. 4.6.4.3 Argentina
    4. 4.6.4.4 Rest of South America
  5. 4.6.5 MEA
    1. 4.6.5.1 GCC Countries
    2. 4.6.5.2 South Africa
    3. 4.6.5.3 Rest of MEA
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 United Surgical Partners International (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Surgical Care Affiliates (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Ambulatory Surgery Centers of America (US)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 HCA Healthcare (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Tenet Healthcare (US)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 Mednax (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Surgery Partners (US)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Envision Healthcare (US)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Cedar Gate Technologies (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 NORTH AMERICA MARKET ANALYSIS
3. 6.3 US MARKET ANALYSIS BY PROCEDURE TYPE
4. 6.4 US MARKET ANALYSIS BY ENDOSCOPY TYPE
5. 6.5 US MARKET ANALYSIS BY IMAGING MODALITY
6. 6.6 US MARKET ANALYSIS BY PATIENT POPULATION
7. 6.7 US MARKET ANALYSIS BY LEVEL OF CARE
8. 6.8 CANADA MARKET ANALYSIS BY PROCEDURE TYPE
9. 6.9 CANADA MARKET ANALYSIS BY ENDOSCOPY TYPE
10. 6.10 CANADA MARKET ANALYSIS BY IMAGING MODALITY
11. 6.11 CANADA MARKET ANALYSIS BY PATIENT POPULATION
12. 6.12 CANADA MARKET ANALYSIS BY LEVEL OF CARE
13. 6.13 EUROPE MARKET ANALYSIS
14. 6.14 GERMANY MARKET ANALYSIS BY PROCEDURE TYPE
15. 6.15 GERMANY MARKET ANALYSIS BY ENDOSCOPY TYPE
16. 6.16 GERMANY MARKET ANALYSIS BY IMAGING MODALITY
17. 6.17 GERMANY MARKET ANALYSIS BY PATIENT POPULATION
18. 6.18 GERMANY MARKET ANALYSIS BY LEVEL OF CARE
19. 6.19 UK MARKET ANALYSIS BY PROCEDURE TYPE
20. 6.20 UK MARKET ANALYSIS BY ENDOSCOPY TYPE
21. 6.21 UK MARKET ANALYSIS BY IMAGING MODALITY
22. 6.22 UK MARKET ANALYSIS BY PATIENT POPULATION
23. 6.23 UK MARKET ANALYSIS BY LEVEL OF CARE
24. 6.24 FRANCE MARKET ANALYSIS BY PROCEDURE TYPE
25. 6.25 FRANCE MARKET ANALYSIS BY ENDOSCOPY TYPE
26. 6.26 FRANCE MARKET ANALYSIS BY IMAGING MODALITY
27. 6.27 FRANCE MARKET ANALYSIS BY PATIENT POPULATION
28. 6.28 FRANCE MARKET ANALYSIS BY LEVEL OF CARE
29. 6.29 RUSSIA MARKET ANALYSIS BY PROCEDURE TYPE
30. 6.30 RUSSIA MARKET ANALYSIS BY ENDOSCOPY TYPE
31. 6.31 RUSSIA MARKET ANALYSIS BY IMAGING MODALITY
32. 6.32 RUSSIA MARKET ANALYSIS BY PATIENT POPULATION
33. 6.33 RUSSIA MARKET ANALYSIS BY LEVEL OF CARE
34. 6.34 ITALY MARKET ANALYSIS BY PROCEDURE TYPE
35. 6.35 ITALY MARKET ANALYSIS BY ENDOSCOPY TYPE
36. 6.36 ITALY MARKET ANALYSIS BY IMAGING MODALITY
37. 6.37 ITALY MARKET ANALYSIS BY PATIENT POPULATION
38. 6.38 ITALY MARKET ANALYSIS BY LEVEL OF CARE
39. 6.39 SPAIN MARKET ANALYSIS BY PROCEDURE TYPE
40. 6.40 SPAIN MARKET ANALYSIS BY ENDOSCOPY TYPE
41. 6.41 SPAIN MARKET ANALYSIS BY IMAGING MODALITY
42. 6.42 SPAIN MARKET ANALYSIS BY PATIENT POPULATION
43. 6.43 SPAIN MARKET ANALYSIS BY LEVEL OF CARE
44. 6.44 REST OF EUROPE MARKET ANALYSIS BY PROCEDURE TYPE
45. 6.45 REST OF EUROPE MARKET ANALYSIS BY ENDOSCOPY TYPE
46. 6.46 REST OF EUROPE MARKET ANALYSIS BY IMAGING MODALITY
47. 6.47 REST OF EUROPE MARKET ANALYSIS BY PATIENT POPULATION
48. 6.48 REST OF EUROPE MARKET ANALYSIS BY LEVEL OF CARE
49. 6.49 APAC MARKET ANALYSIS
50. 6.50 CHINA MARKET ANALYSIS BY PROCEDURE TYPE
51. 6.51 CHINA MARKET ANALYSIS BY ENDOSCOPY TYPE
52. 6.52 CHINA MARKET ANALYSIS BY IMAGING MODALITY
53. 6.53 CHINA MARKET ANALYSIS BY PATIENT POPULATION
54. 6.54 CHINA MARKET ANALYSIS BY LEVEL OF CARE
55. 6.55 INDIA MARKET ANALYSIS BY PROCEDURE TYPE
56. 6.56 INDIA MARKET ANALYSIS BY ENDOSCOPY TYPE
57. 6.57 INDIA MARKET ANALYSIS BY IMAGING MODALITY
58. 6.58 INDIA MARKET ANALYSIS BY PATIENT POPULATION
59. 6.59 INDIA MARKET ANALYSIS BY LEVEL OF CARE
60. 6.60 JAPAN MARKET ANALYSIS BY PROCEDURE TYPE
61. 6.61 JAPAN MARKET ANALYSIS BY ENDOSCOPY TYPE
62. 6.62 JAPAN MARKET ANALYSIS BY IMAGING MODALITY
63. 6.63 JAPAN MARKET ANALYSIS BY PATIENT POPULATION
64. 6.64 JAPAN MARKET ANALYSIS BY LEVEL OF CARE
65. 6.65 SOUTH KOREA MARKET ANALYSIS BY PROCEDURE TYPE
66. 6.66 SOUTH KOREA MARKET ANALYSIS BY ENDOSCOPY TYPE
67. 6.67 SOUTH KOREA MARKET ANALYSIS BY IMAGING MODALITY
68. 6.68 SOUTH KOREA MARKET ANALYSIS BY PATIENT POPULATION
69. 6.69 SOUTH KOREA MARKET ANALYSIS BY LEVEL OF CARE
70. 6.70 MALAYSIA MARKET ANALYSIS BY PROCEDURE TYPE
71. 6.71 MALAYSIA MARKET ANALYSIS BY ENDOSCOPY TYPE
72. 6.72 MALAYSIA MARKET ANALYSIS BY IMAGING MODALITY
73. 6.73 MALAYSIA MARKET ANALYSIS BY PATIENT POPULATION
74. 6.74 MALAYSIA MARKET ANALYSIS BY LEVEL OF CARE
75. 6.75 THAILAND MARKET ANALYSIS BY PROCEDURE TYPE
76. 6.76 THAILAND MARKET ANALYSIS BY ENDOSCOPY TYPE
77. 6.77 THAILAND MARKET ANALYSIS BY IMAGING MODALITY
78. 6.78 THAILAND MARKET ANALYSIS BY PATIENT POPULATION
79. 6.79 THAILAND MARKET ANALYSIS BY LEVEL OF CARE
80. 6.80 INDONESIA MARKET ANALYSIS BY PROCEDURE TYPE
81. 6.81 INDONESIA MARKET ANALYSIS BY ENDOSCOPY TYPE
82. 6.82 INDONESIA MARKET ANALYSIS BY IMAGING MODALITY
83. 6.83 INDONESIA MARKET ANALYSIS BY PATIENT POPULATION
84. 6.84 INDONESIA MARKET ANALYSIS BY LEVEL OF CARE
85. 6.85 REST OF APAC MARKET ANALYSIS BY PROCEDURE TYPE
86. 6.86 REST OF APAC MARKET ANALYSIS BY ENDOSCOPY TYPE
87. 6.87 REST OF APAC MARKET ANALYSIS BY IMAGING MODALITY
88. 6.88 REST OF APAC MARKET ANALYSIS BY PATIENT POPULATION
89. 6.89 REST OF APAC MARKET ANALYSIS BY LEVEL OF CARE
90. 6.90 SOUTH AMERICA MARKET ANALYSIS
91. 6.91 BRAZIL MARKET ANALYSIS BY PROCEDURE TYPE
92. 6.92 BRAZIL MARKET ANALYSIS BY ENDOSCOPY TYPE
93. 6.93 BRAZIL MARKET ANALYSIS BY IMAGING MODALITY
94. 6.94 BRAZIL MARKET ANALYSIS BY PATIENT POPULATION
95. 6.95 BRAZIL MARKET ANALYSIS BY LEVEL OF CARE
96. 6.96 MEXICO MARKET ANALYSIS BY PROCEDURE TYPE
97. 6.97 MEXICO MARKET ANALYSIS BY ENDOSCOPY TYPE
98. 6.98 MEXICO MARKET ANALYSIS BY IMAGING MODALITY
99. 6.99 MEXICO MARKET ANALYSIS BY PATIENT POPULATION
100. 6.100 MEXICO MARKET ANALYSIS BY LEVEL OF CARE
101. 6.101 ARGENTINA MARKET ANALYSIS BY PROCEDURE TYPE
102. 6.102 ARGENTINA MARKET ANALYSIS BY ENDOSCOPY TYPE
103. 6.103 ARGENTINA MARKET ANALYSIS BY IMAGING MODALITY
104. 6.104 ARGENTINA MARKET ANALYSIS BY PATIENT POPULATION
105. 6.105 ARGENTINA MARKET ANALYSIS BY LEVEL OF CARE
106. 6.106 REST OF SOUTH AMERICA MARKET ANALYSIS BY PROCEDURE TYPE
107. 6.107 REST OF SOUTH AMERICA MARKET ANALYSIS BY ENDOSCOPY TYPE
108. 6.108 REST OF SOUTH AMERICA MARKET ANALYSIS BY IMAGING MODALITY
109. 6.109 REST OF SOUTH AMERICA MARKET ANALYSIS BY PATIENT POPULATION
110. 6.110 REST OF SOUTH AMERICA MARKET ANALYSIS BY LEVEL OF CARE
111. 6.111 MEA MARKET ANALYSIS
112. 6.112 GCC COUNTRIES MARKET ANALYSIS BY PROCEDURE TYPE
113. 6.113 GCC COUNTRIES MARKET ANALYSIS BY ENDOSCOPY TYPE
114. 6.114 GCC COUNTRIES MARKET ANALYSIS BY IMAGING MODALITY
115. 6.115 GCC COUNTRIES MARKET ANALYSIS BY PATIENT POPULATION
116. 6.116 GCC COUNTRIES MARKET ANALYSIS BY LEVEL OF CARE
117. 6.117 SOUTH AFRICA MARKET ANALYSIS BY PROCEDURE TYPE
118. 6.118 SOUTH AFRICA MARKET ANALYSIS BY ENDOSCOPY TYPE
119. 6.119 SOUTH AFRICA MARKET ANALYSIS BY IMAGING MODALITY
120. 6.120 SOUTH AFRICA MARKET ANALYSIS BY PATIENT POPULATION
121. 6.121 SOUTH AFRICA MARKET ANALYSIS BY LEVEL OF CARE
122. 6.122 REST OF MEA MARKET ANALYSIS BY PROCEDURE TYPE
123. 6.123 REST OF MEA MARKET ANALYSIS BY ENDOSCOPY TYPE
124. 6.124 REST OF MEA MARKET ANALYSIS BY IMAGING MODALITY
125. 6.125 REST OF MEA MARKET ANALYSIS BY PATIENT POPULATION
126. 6.126 REST OF MEA MARKET ANALYSIS BY LEVEL OF CARE
127. 6.127 KEY BUYING CRITERIA OF HEALTHCARE
128. 6.128 RESEARCH PROCESS OF MRFR
129. 6.129 DRO ANALYSIS OF HEALTHCARE
130. 6.130 DRIVERS IMPACT ANALYSIS: HEALTHCARE
131. 6.131 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
132. 6.132 SUPPLY / VALUE CHAIN: HEALTHCARE
133. 6.133 HEALTHCARE, BY PROCEDURE TYPE, 2024 (% SHARE)
134. 6.134 HEALTHCARE, BY PROCEDURE TYPE, 2024 TO 2035 (USD Billion)
135. 6.135 HEALTHCARE, BY ENDOSCOPY TYPE, 2024 (% SHARE)
136. 6.136 HEALTHCARE, BY ENDOSCOPY TYPE, 2024 TO 2035 (USD Billion)
137. 6.137 HEALTHCARE, BY IMAGING MODALITY, 2024 (% SHARE)
138. 6.138 HEALTHCARE, BY IMAGING MODALITY, 2024 TO 2035 (USD Billion)
139. 6.139 HEALTHCARE, BY PATIENT POPULATION, 2024 (% SHARE)
140. 6.140 HEALTHCARE, BY PATIENT POPULATION, 2024 TO 2035 (USD Billion)
141. 6.141 HEALTHCARE, BY LEVEL OF CARE, 2024 (% SHARE)
142. 6.142 HEALTHCARE, BY LEVEL OF CARE, 2024 TO 2035 (USD Billion)
143. 6.143 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 North America MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.2.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.2.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.2.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.2.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
2. 7.3 US MARKET SIZE ESTIMATES; FORECAST
  1. 7.3.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.3.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.3.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.3.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.3.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
3. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST
  1. 7.4.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.4.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.4.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.4.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.4.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
4. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.5.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.5.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.5.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.5.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.5.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
5. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST
  1. 7.6.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.6.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.6.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.6.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.6.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
6. 7.7 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.7.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.7.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.7.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.7.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.7.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
7. 7.8 France MARKET SIZE ESTIMATES; FORECAST
  1. 7.8.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.8.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.8.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.8.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.8.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
8. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST
  1. 7.9.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.9.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.9.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.9.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.9.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
9. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST
  1. 7.10.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.10.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.10.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.10.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.10.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
10. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST
  1. 7.11.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.11.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.11.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.11.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.11.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
11. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST
  1. 7.12.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.12.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.12.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.12.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.12.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
12. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.13.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.13.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.13.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.13.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.13.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
13. 7.14 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.14.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.14.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.14.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.14.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.14.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
14. 7.15 India MARKET SIZE ESTIMATES; FORECAST
  1. 7.15.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.15.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.15.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.15.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.15.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
15. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST
  1. 7.16.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.16.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.16.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.16.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.16.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
16. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST
  1. 7.17.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.17.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.17.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.17.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.17.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
17. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST
  1. 7.18.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.18.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.18.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.18.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.18.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
18. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST
  1. 7.19.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.19.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.19.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.19.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.19.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
19. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST
  1. 7.20.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.20.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.20.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.20.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.20.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
20. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST
  1. 7.21.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.21.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.21.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.21.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.21.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
21. 7.22 South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.22.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.22.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.22.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.22.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.22.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
22. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST
  1. 7.23.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.23.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.23.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.23.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.23.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
23. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST
  1. 7.24.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.24.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.24.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.24.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.24.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
24. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST
  1. 7.25.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.25.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.25.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.25.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.25.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
25. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST
  1. 7.26.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.26.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.26.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.26.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.26.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
26. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.27.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.27.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.27.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.27.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.27.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
27. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST
  1. 7.28.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.28.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.28.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.28.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.28.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
28. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST
  1. 7.29.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.29.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.29.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.29.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.29.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
29. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST
  1. 7.30.1 BY PROCEDURE TYPE, 2025-2035 (USD Billion)
  2. 7.30.2 BY ENDOSCOPY TYPE, 2025-2035 (USD Billion)
  3. 7.30.3 BY IMAGING MODALITY, 2025-2035 (USD Billion)
  4. 7.30.4 BY PATIENT POPULATION, 2025-2035 (USD Billion)
  5. 7.30.5 BY LEVEL OF CARE, 2025-2035 (USD Billion)
30. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.31.1
1. 7.32 ACQUISITION/PARTNERSHIP
7.32.1

Certified Researchers

Customize Report

Healthcare Market Segmentation

Healthcare By Procedure Type (USD Billion, 2025-2035)

Gastrointestinal Endoscopy
Colon and Rectal Surgery
Upper Gastrointestinal Surgery
Laparoscopic Surgery
Endoscopic Retrograde Cholangiopancreatography (ERCP)
Percutaneous Endoscopic Gastrostomy (PEG) Tube Placement
Esophageal Dilatation
Endoscopic Mucosal Resection (EMR)
Endoscopic Submucosal Dissection (ESD)

Healthcare By Endoscopy Type (USD Billion, 2025-2035)

Upper Endoscopy
Lower Endoscopy
Capsule Endoscopy
Wireless Capsule Endoscopy
Double-Balloon Endoscopy

Healthcare By Imaging Modality (USD Billion, 2025-2035)

Fluoroscopy
Ultrasound
Magnetic Resonance Imaging (MRI)
Computed Tomography (CT)

Healthcare By Patient Population (USD Billion, 2025-2035)

Adults
Children
Geriatric Patients

Healthcare By Level of Care (USD Billion, 2025-2035)

Same-Day Surgery
Observation
Inpatient

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”

Rob Kooiker Group Product Manager HVAC & Fire Protection GMA

“We got the report in time, we really thank you for your support in this process. I also thank to all of your team as they did a great job.”

Akif Moroglu Strategy & Business Development Director

Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Features	License Type
Features	Single User	Multiuser License	Enterprise User
Price	$4,950	$5,950	$7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout the Organization
Free Customization	✓	✓	✓
Direct Access to Analyst	✓	✓	✓
Deliverable Format	✓	✓	✓
Platform Access	✗	✗	✓
Discount on Next Purchase	10%	15%	15%
Printable Versions	✗	✗	✓